Ultimately, our study demonstrates that the potential of SEB to modulate AAI is exceptionally versatile and at different levels can affect allergic sensitization, inflammation as well as airway hyperreactivity (Table 1). The gene discussed is SETBP1; the disease is hypersensitivity reaction disease.